Affinity Biopharma

亲合力

Affinity Biopharma

Biotech/Healthcare

Aptamer Group is a clinical-stage biopharmaceutical company focused on developing innovative oncology drugs globally. It owns a first-in-class proprietary chemical conjugation technology and an exclusive linker that can upgrade conventional drugs into novel precision-guided therapies delivered to…

Latest round: Series A Extension (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-07-01